Skip to content

Form 4 filed by Collins Helen Louise

Collins Helen Louise filed this Form 4 on ELVN (Enliven Therapeutics, Inc.) with 4 transaction rows and 0 holding rows, accepted by EDGAR 2026-11-19 22:07:34 UTC.

Accession
0001701247-26-000015
Filed
2026-11-19
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

Issuer and reporting owners

Issuer: ELVN · Enliven Therapeutics, Inc. (CIK 1672619)

Rows

SecurityDateCodeSharesPriceOwned afterOwnership
Common Stock 2026-11-17M exercised+5,000$2.4830,000D
Common Stock 2026-11-17S sold-4,939$46.831325,061D
Common Stock 2026-11-17S sold-61$47.595425,000D
Stock Option (right to buy) derivative2026-11-17M exercised-5,000$096,268D